Conventional anti-dementia treatment group is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Cuibai Wei๏ผClinical Professor (1) and First Affiliated Hospital of Wenzhou Medical University (1). Registered phases: Observational and Phase 4. Conditions studied include Alzheimer's Disease; Lecanemab; Functional Magnetic Resonance Imaging.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07604896 | Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs (ClinicalTrials.gov ↗) Alzheimer s Disease, Alzheimer Dementia (AD), MCI-AD, Early Stage Alzheimer's Disease |
Phase 4 | Recruiting |
| NCT06871839 | The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease (ClinicalTrials.gov ↗) Alzheimer's Disease, Lecanemab, Functional Magnetic Resonance Imaging |
Observational | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Alzheimer's Disease | 1 |
| Lecanemab | 1 |
| Functional Magnetic Resonance Imaging | 1 |
| Alzheimer s Disease | 1 |
| Alzheimer Dementia (AD) | 1 |
| MCI-AD, Early Stage Alzheimer's Disease | 1 |
| Lead sponsor | Trials |
|---|---|
| Cuibai Wei๏ผClinical Professor | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Register | Conventional anti-dementia treatment group trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Conventional anti-dementia treatment group works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Conventional anti-dementia treatment group (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.